Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties - Top-Institutions - MDSpire

Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties

  • By

  • Wendy Yi-Ying Wu

  • Barbro Numan Hellquist

  • Beatrice Melin

  • Benny Björkblom

  • Rickard L. Sjöberg

  • June 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Umeå University Hospital
    Umeå University Hospital

    Umeå, Västerbotten

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Columbia University Medical Center
    Columbia University Medical Center

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    University of California, Los Angeles
    University of California, Los Angeles

    Los Angeles, California

    Key Differentiators

    • Oncology

Original Source(s)

Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties

  • by Wendy Yi-Ying Wu, Barbro Numan Hellquist, Beatrice Melin, Benny Björkblom, Rickard L. Sjöberg

  • June 30, 2026

Related Content

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics

Symptom clusters and sentinel symptoms in colorectal cancer patients during post-operative chemotherapy

Case report: A case of adolescent invasive encapsulated follicular variant of papillary thyroid carcinoma with literature review